Post-insult ibuprofen treatment attenuates damage to the serotonergic system after hypoxia-ischemia in the immature rat brain

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 12, 2012, Pages 1137-1148

  Wixey, Julie A ^a   Reinebrant, Hanna E ^a   Buller, Kathryn M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Brainstem; Cyclooxygenase enzymes; Hypoxia ischemia; Ibuprofen; Preterm neonate; Raph ; Serotonin

Indexed keywords

CYCLOOXYGENASE 2; IBUPROFEN; INTERLEUKIN 1BETA; PROSTAGLANDIN SYNTHASE; SEROTONIN TRANSPORTER; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CAROTID ARTERY LIGATION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ENZYME INHIBITION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONINERGIC SYSTEM;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN; BRAIN INJURIES; CALCIUM-BINDING PROTEINS; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL LATERALITY; HYPOXIA-ISCHEMIA, BRAIN; IBUPROFEN; MICROFILAMENT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84870847430     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318277d4c7     Document Type: Article

References (73)

1. Hack M, Youngstrom EA, Cartar L, et al. Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 2004;114:932-40
2. O'Brien F, Roth S, Stewart A, et al. The neurodevelopmental progress of infants less than 33 weeks into adolescence. Arch Dis Child 2004; 89:207-11
3. Peterson BS, Anderson AW, Ehrenkranz R, et al. Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics 2003;111:939-48
4. Jacobs SE, Morley CJ, Inder TE, et al. Infant cooling evaluation C. Whole-body hypothermia for term and near-term newborns with hypoxicischemic encephalopathy: A randomized controlled trial. Arch Pediatr Adolesc Med 2011;165:692-700
5. Reinebrant HE, Wixey JA, Gobe GC, et al. Differential effects of neonatal hypoxic-ischemic brain injury on brainstem serotonergic raphe nuclei. Brain Res 2010;1322C:124-33
6. Wixey JA, Reinebrant HE, Buller KM. Inhibition of neuroinflammation prevents injury to the serotonergic network after hypoxia-ischemia in the immature rat brain. J Neuropathol Exp Neurol 2011;70:23-35
7. Wixey JA, Reinebrant HE, Spencer SJ, et al. Efficacy of post-insult minocycline administration to alter long-term hypoxia-ischemia-induced damage to the serotonergic system in the immature rat brain. Neuroscience 2011;182:184-92
8. Wixey JA, Reinebrant HE, Buller KM. Evidence that the serotonin transporter does not shift into the cytosol of remaining neurons after neonatal brain injury. Neurosci Res 2012;73:252-56
9. Logitharajah P, Rutherford MA, Cowan FM. Hypoxic-ischemic encephalopathy in preterm infants: Antecedent factors, brain imaging, and outcome. Pediatr Res 2009;66:222-29
10. Duncan JR, Paterson DS, Hoffman JM, et al. Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA 2010;303:430-37
11. Gartside SE, Johnson DA, Leitch MM, et al. Early life adversity programs changes in central 5-HT neuronal function in adulthood. Eur J Neurosci 2003;17:2401-8
12. Nemeroff CB, Owens MJ. The role of serotonin in the pathophysiology of depression: As important as ever. Clin Chem 2009;55:1578-79
13. Pardo CA, Eberhart CG. The neurobiology of autism. Brain Pathol 2007; 17:434-47
14. Buller KM, Wixey JA, Reinebrant HE. Disruption of the serotonergic system after neonatal hypoxia-ischemia in a rodent model. Neurol Res Int 2012;2012:12
15. Bona E, Andersson AL, Blomgren K, et al. Chemokine and inflammatory cell response to hypoxia ischemia in immature rats. Pediatr Res 1999;45: 500-9
16. Kremlev SG, Roberts RL, Palmer C. Minocycline modulates chemokine receptors but not interleukin-10 mRNA expression in hypoxic-ischemic neonatal rat brain. J Neurosci Res 2007;85:2450-59
17. Wixey JA, Reinebrant HE, Carty ML, et al. Delayed P2X4R expression after hypoxia-ischemia is associated with microglia in the immature rat brain. J Neuroimmunol 2009;212:35-43
18. Laurence DR, Bennett PN, eds. Clinical Pharmacology. 6th Ed. New York, NY: Churchill Livingstone, 1987
19. Buller KM, Carty ML, Reinebrant HE, et al. Minocycline: A neuroprotective agent for hypoxic-ischemic brain injury in the neonate? J Neurosci Res 2009;87:599-608
20. Varvarigou A, Bardin CL, Beharry K, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996;275:539-44
21. Domoki F, Perciaccante JV, Puskar M, et al. Cyclooxygenase-2 inhibitor NS398 preserves neuronal function after hypoxia/ischemia in piglets. Neuroreport 2001;12:4065-68
22. Fathali N, Ostrowski RP, Lekic T, et al. Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury. Crit Care Med 2010;38:572-78
23. Carty ML, Wixey JA, Reinebrant HE, et al. Ibuprofen inhibits neuroinflammation and attenuates white matter damage following hypoxiaischemia in the immature rodent brain. Brain Res 2011;1402:9-19
24. Cole DJ, Patel PM, Reynolds L, et al. Temporary focal cerebral ischemia in spontaneously hypertensive rats: The effect of ibuprofen on infarct volume. J Pharmacol Exp Ther 1993;266:1713-17
25. Park EM, Cho BP, Volpe BT, et al. Ibuprofen protects ischemia-induced neuronal injury via upregulating interleukin-1 receptor antagonist expression. Neuroscience 2005;132:625-31
26. Lim GP, Yang F, Chu T, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 2000;20:5709-14
27. Buller KM, Wixey JA, Pathipati P, et al. Selective losses of brainstem catecholamine neurons after hypoxia-ischemia in the immature rat pup. Pediatr Res 2008;63:364-69
28. Antezana DF, Clatterbuck RE, Alkayed NJ, et al. High-dose ibuprofen for reduction of striatal infarcts during middle cerebral artery occlusion in rats. J Neurosurg 2003;98:860-66
29. Smith DW, Buller KM, Day TA. Role of ventrolateral medulla catecholamine cells in hypothalamic neuroendocrine cell responses to systemic hypoxia. J Neurosci 1995;15:7979-88
30. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press, 1997
31. Kreutzberg GW. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-18
32. Hornung JP. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003;26:331-43
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-85
34. Hayashi M, Itoh M, Araki S, et al. Immunohistochemical analysis of brainstem lesions in infantile spasms. Neuropathology 2000;20:297-303
35. Reinebrant HE, Wixey JA, Buller KM. Disruption of raphe? serotonergic neural projections to the cortex: A potential pathway contributing to remote loss of brainstem neurons following neonatal hypoxic-ischemic brain injury. Eur J Neurosci [epub ahead of print] September 4, 2012. doi:10.1111/j.1460-9568. 2012.08276.x
36. Chavez-Valdez R, Martin LJ, Northington FJ. Programmed necrosis: A prominent mechanism of cell death following neonatal brain injury. Neurol Res Int 2012;2012:12
37. Peng J-HF, Feng Y, LeBlanc MH, et al. Apoptosis and necrosis in developing cerebellum and brainstem induced after focal cerebral hypoxicischemic injury. Dev Brain Res 2005;156:87-92
38. Tomimatsu T, Fukuda H, Endoh M, et al. Effects of neonatal hypoxic-ischemic brain injury on skilled motor tasks and brainstem function in adult rats. Brain Res 2002;926:108-17
39. Iwata Y, Nicole O, Zurakowski D, et al. Ibuprofen for neuroprotection after cerebral ischemia. J Thorac Cardiovasc Surg 2010;139:489-93
40. Lipsanen A, Hiltunen M, Jolkkonen J. Chronic ibuprofen treatment does not affect the secondary pathology in the thalamus or improve behavioral outcome in middle cerebral artery occlusion rats. Pharmacol Biochem Behav 2011;99:468-74
41. Wang X, Baumann MH, Xu H, et al. 3,4-Methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse 2004;53:240-48
42. Tutak E, Satar M, Zorludemir S, et al. Neuroprotective effects of indomethacin and aminoguanidine in the newborn rats with hypoxic-ischemic cerebral injury. Neurochem Res 2005;30:937-42
43. Taskin E, Ozcan K, Canacankatan N, et al. The effects of indomethacin on caspases, glutathione level and lipid peroxidation in the newborn rats with hypoxic-ischemic cerebral injury. Brain Res 2009;1289:118-23
44. Pierson CR, Folkerth RD, Billiards SS, et al. Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathol 2007;114:619-31
45. Volpe JJ. Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009;8:110-24
46. Leviton A, Gressens P. Neuronal damage accompanies perinatal whitematter damage. Trends Neurosci 2007;30:473-78
47. Kokki H, Kumpulainen E, Lehtonen M, et al. Cerebrospinal fluid distribution of ibuprofen after intravenous administration in children. Pediatrics 2007;120:e1002-8
48. Parepally JM, Mandula H, Smith QR. Brain uptake of nonsteroidal antiinflammatory drugs: Ibuprofen, flurbiprofen, and indomethacin. Pharmacol Res 2006;23:873-81
49. Li RC. Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat. Am J Respir Crit Care Med 2003;168:469-75
50. Candelario-Jalil E, Gonzalez-Falcon A, Garca-Cabrera M, et al. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat. Brain Res 2004;1007:98-108
51. Pascual M, Blanco AM, Cauli O, et al. Intermittent ethanol exposure induces inflammatory brain damage and causes long-term behavioral alterations in adolescent rats. Eur J Neurosci 2007;25:541-50
52. Aly H, Abd-Rabboh L, El-Dib M, et al. Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: A randomized controlled trial. J Perinatol 2009;29:438-43
53. Choi SH, Aid S, Bosetti F. The distinct roles of cyclooxygenase-1 and-2 in neuroinflammation: Implications for translational research. Trends Pharmacol Sci 2009;30:174-81
54. Nogawa S, Zhang F, Ross ME, et al. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997;17: 2746-55
55. Collaco-Moraes Y, Aspey B, Harrison M, et al. Cyclooxygenase-2 messenger RNA induction in focal cerebral ischemia. J Cereb Blood Flow Metab 1996;16:1366-72
56. Ahmad M, Zhang Y, Liu H, et al. Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity. Brain Res 2009;1279:168-73
57. Dore S, Otsuka T, Mito T, et al. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann Neurol 2003;54:155-62
58. Xiang Z, Thomas S, Pasinetti G. Increased neuronal injury in transgenic mice with neuronal overexpression of human cyclooxygenase-2 is reversed by hypothermia and rofecoxib treatment. Curr Neurovasc Res 2007;4:274-79
59. Iadecola C, Niwa K, Nogawa S, et al. Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartateYmediated neurotoxicity in cyclooxygenase-2Ydeficient mice. Proc Natl Acad Sci USA 2001;98:1294-99
60. Sasaki T, Kitagawa K, Yamagata K, et al. Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2Y deficient mice. J Cereb Blood Flow Metab 2004;24:107-13
61. Toti P, De Felice C, Schurfeld K, et al. Cyclooxygenase-2 immunoreactivity in the ischemic neonatal human brain. An autopsy study. J Submicrosc Cytol Pathol 2001;33:245-49
62. Yin W, Signore AP, Iwai M, et al. Preconditioning suppresses inflammation in neonatal hypoxic ischemia via akt activation. Stroke 2007;38: 1017-24
63. Biran V, Joly L-M, Heron A, et al. Glial activation in white matter following ischemia in the neonatal P7 rat brain. Exp Neurol 2006;199: 103-12
64. McRae A, Gilland E, Bona E, et al. Microglia activation after neonatal hypoxic-ischemia. Brain Res Dev Brain Res 1995;84:245-52
65. Bauer MK, Lieb K, Schulze-Osthoff K, et al. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 1997;243:726-31
66. Tomimoto H, Akiguchi I, Wakita H, et al. Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans. Acta Neuropathol 2000;99:26-30
67. Combs CK, Johnson DE, Karlo JC, et al. Inflammatory mechanisms in Alzheimer's disease: Inhibition of beta-amyloidYstimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci 2000;20:558-67
68. Shen H, Hu X, Liu C, et al. Ethyl pyruvate protects against hypoxicischemic brain injury via anti-cell death and anti-inflammatory mechanisms. Neurobiol Dis 2010;37:711-22
69. Vannucci RC, Lyons DT, Vasta F. Regional cerebral blood flow during hypoxia-ischemia in immature rats. Stroke 1988;19:245-50
70. Tatli MM, Kumral A, Duman N, et al. Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two verylow-birthweight infants. Acta Pediatr 2004;93:999-1001
71. Ambat MT, Ostrea EM Jr, Aranda JV. Effect of ibuprofen L-lysinate on bilirubin binding to albumin as measured by saturation index and horseradish peroxidase assays. J Perinatol 2008;28:287-90
72. Gournay V, Savagner C, Thiriez G, et al. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002;359: 1486-88
73. Desfrere L, Zohar S, Morville P, et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharmacol Ther 2005;30:121-32.